University Of Maryland Medical System Series 2021B Bonds Assigned 'A' Rating - S&P Global Ratings’ Credit Research

University Of Maryland Medical System Series 2021B Bonds Assigned 'A' Rating

University Of Maryland Medical System Series 2021B Bonds Assigned 'A' Rating - S&P Global Ratings’ Credit Research
University Of Maryland Medical System Series 2021B Bonds Assigned 'A' Rating
Published Feb 08, 2022
3 pages (1566 words) — Published Feb 08, 2022
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

NEW YORK (S&P Global Ratings) Feb. 8, 2022--S&P Global Ratings assigned its 'A' long-term rating to Maryland Health&Higher Education Facilities Authority's (MHHEFA) $107.5 million tax-exempt series 2021B bonds, issued for University of Maryland Medical System (UMMS), purchased directly by Barclay's. In addition, S&P Global Ratings affirmed its 'A' long-term rating on various health care revenue bonds outstanding issued for UMMS. The outlook is stable. S&P Global Ratings also affirmed the 'AA+/A-1+' rating on MHHEFA's series 2008D variable-rate revenue bonds. The rating on these bonds reflects the application of our low-correlation joint criteria. The long-term component of the rating is based jointly on a bank-supported letter of credit (LOC) and our 'A' underlying rating on UMMS. The short-term component

  
Brief Excerpt:

...February 8, 2022 NEW YORK (S&P Global Ratings) Feb. 8, 2022--S&P Global Ratings assigned its 'A' long-term rating to Maryland Health & Higher Education Facilities Authority's (MHHEFA) $107.5 million tax-exempt series 2021B bonds, issued for University of Maryland Medical System (UMMS), purchased directly by Barclay's. In addition, S&P Global Ratings affirmed its 'A' long-term rating on various health care revenue bonds outstanding issued for UMMS. The outlook is stable. S&P Global Ratings also affirmed the '##+/A-1+' rating on MHHEFA's series 2008D variable-rate revenue bonds. The rating on these bonds reflects the application of our low-correlation joint criteria. The long-term component of the rating is based jointly on a bank-supported letter of credit (LOC) and our 'A' underlying rating on UMMS. The short-term component of the rating is based solely on the rating on the LOC provider, which is TD Bank N.A. "The rating reflects UMMS' favorable enterprise profile characterized by a sound...

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers, Public Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "University Of Maryland Medical System Series 2021B Bonds Assigned 'A' Rating" Feb 08, 2022. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/University-Of-Maryland-Medical-System-Series-2021B-Bonds-Assigned-A-Rating-2792891>
  
APA:
S&P Global Ratings’ Credit Research. (). University Of Maryland Medical System Series 2021B Bonds Assigned 'A' Rating Feb 08, 2022. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/University-Of-Maryland-Medical-System-Series-2021B-Bonds-Assigned-A-Rating-2792891>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.